KYPROLIS
Dr Reddy's Laboratories inks pact with Amgen to commercialise three drugs in IndiaUnder the terms, DRL will commercialise Xgeva (denosumab), Vectibix (panitumumab) and Prolia (denosumab) in India, a company statement said...16 Sep, 2016, 05.02 PM IST
Dr Reddy's Lab shares up almost 2% on boursesShares of Dr Reddy's Laboratories rose almost 2% after the company said it has inked a pact with US-based biotechnology firm Amgen to marke...06 Aug, 2015, 06.15 PM IST
Dr Reddy's to market three Amgen drugs in IndiaDr Reddy's Laboratories today said it has inked a pact with US-based biotechnology firm Amgen to market its three drugs.06 Aug, 2015, 12.59 PM IST
Load More